BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY
Deodhar A, Van der Heijde D, Gensler LS, Xu H, Gaffney K, Dobashi H, Maksymowych WP, Rudwaleit M, Magrey M, Elewaut D, Oortgiesen M, et al. (2022)
In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 772-773.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Deodhar, A.;
Van der Heijde, D.;
Gensler, L. S.;
Xu, H.;
Gaffney, K.;
Dobashi, H.;
Maksymowych, W. P.;
Rudwaleit, MartinUniBi;
Magrey, M.;
Elewaut, D.;
Oortgiesen, M.;
Fleurinck, C.
Alle
Alle
Einrichtung
Erscheinungsjahr
2022
Titel des Konferenzbandes
Annals of the Rheumatic Diseases
Band
81
Ausgabe
Suppl. 1
Seite(n)
772-773
ISSN
0003-4967
eISSN
1468-2060
Page URI
https://pub.uni-bielefeld.de/record/2966748
Zitieren
Deodhar A, Van der Heijde D, Gensler LS, et al. BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY. In: Annals of the Rheumatic Diseases. Vol 81. London: Bmj Publishing Group; 2022: 772-773.
Deodhar, A., Van der Heijde, D., Gensler, L. S., Xu, H., Gaffney, K., Dobashi, H., Maksymowych, W. P., et al. (2022). BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY. Annals of the Rheumatic Diseases, 81, 772-773. London: Bmj Publishing Group. https://doi.org/10.1136/annrheumdis-2022-eular.2416
Deodhar, A., Van der Heijde, D., Gensler, L. S., Xu, H., Gaffney, K., Dobashi, H., Maksymowych, W. P., et al. 2022. “BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY”. In Annals of the Rheumatic Diseases, 81:772-773. London: Bmj Publishing Group.
Deodhar, A., Van der Heijde, D., Gensler, L. S., Xu, H., Gaffney, K., Dobashi, H., Maksymowych, W. P., Rudwaleit, M., Magrey, M., Elewaut, D., et al. (2022). “BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY” in Annals of the Rheumatic Diseases, vol. 81, (London: Bmj Publishing Group), 772-773.
Deodhar, A., et al., 2022. BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY. In Annals of the Rheumatic Diseases. no.81 London: Bmj Publishing Group, pp. 772-773.
A. Deodhar, et al., “BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY”, Annals of the Rheumatic Diseases, vol. 81, London: Bmj Publishing Group, 2022, pp.772-773.
Deodhar, A., Van der Heijde, D., Gensler, L.S., Xu, H., Gaffney, K., Dobashi, H., Maksymowych, W.P., Rudwaleit, M., Magrey, M., Elewaut, D., Oortgiesen, M., Fleurinck, C., Ellis, A., Vaux, T., Smith, J., Baraliakos, X.: BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY. Annals of the Rheumatic Diseases. 81, p. 772-773. Bmj Publishing Group, London (2022).
Deodhar, A., Van der Heijde, D., Gensler, L. S., Xu, H., Gaffney, K., Dobashi, H., Maksymowych, W. P., Rudwaleit, Martin, Magrey, M., Elewaut, D., Oortgiesen, M., Fleurinck, C., Ellis, A., Vaux, T., Smith, J., and Baraliakos, X. “BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY”. Annals of the Rheumatic Diseases. London: Bmj Publishing Group, 2022.Vol. 81. 772-773.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar